A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization
- 8 June 2003
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 21 (7) , 771-777
- https://doi.org/10.1038/nbt835
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Replication-selective viruses for cancer therapyJournal of Molecular Medicine, 2001
- Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyNature Biotechnology, 2001
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsNature Medicine, 2001
- Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 FibritinJournal of Virology, 2001
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigenJournal of Clinical Investigation, 2000
- Replicative adenoviruses for cancer therapyNature Biotechnology, 2000
- Cancer gene therapy: hard lessons and new coursesGene Therapy, 2000
- A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular CarcinomaHuman Gene Therapy, 1999
- Gene therapy - promises, problems and prospectsNature, 1997
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996